Glucagon Acting at the GLP-1 Receptor Contributes to β-Cell Regeneration Induced by Glucagon Receptor Antagonism in Diabetic Mice.
葡萄糖素作用於 GLP-1 受體有助於葡萄糖素受體拮抗劑誘導的糖尿病小鼠胰島β細胞再生。
Diabetes 2023-05-14
Mechanisms and clinical applications of incretin therapies for diabetes and chronic kidney disease.
胰高血糖素治療在糖尿病和慢性腎臟病的機制和臨床應用。
Curr Opin Nephrol Hypertens 2023-09-17
Glucagon-like peptide-1 receptor agonists in diabetic kidney disease: A review of their kidney and heart protection.
糖尿病腎病中的葡萄糖樣肽-1 受體激動劑:對腎臟和心臟保護的綜述。
Am J Prev Cardiol 2023-06-15
Glucagon-like peptide-1 receptor signaling modifies the extent of diabetic kidney disease through dampening the receptor for advanced glycation end products-induced inflammation.
葡萄糖樣肽-1 受體信號通路透過抑制高糖基產物受體誘導的發炎,調節糖尿病腎病變的程度。
Kidney Int 2024-01-08
Design and discovery of a highly potent ultralong-acting GLP-1 and glucagon co-agonist for attenuating renal fibrosis.
設計和發現一種高效超長效GLP-1和葡萄糖素共激動劑,用於緩解腎臟纖維化。
Acta Pharm Sin B 2024-03-16
Transforming Diabetes Care: The Molecular Pathways through Which GLP1-RAs Impact the Kidneys in Diabetic Kidney Disease.
改變糖尿病護理:GLP1-RAs 如何影響糖尿病腎病的分子途徑。
Biomedicines 2024-03-30
Renal Function Improvement With Glucagon-Like Peptide-1 Receptor Agonist in a Patient With Type 2 Diabetes.
糖尿病患者使用胰高血糖素樣肽-1受體激動劑改善腎功能。
J Med Cases 2024-04-23